Our Best Shot: Utilizing Long-Acting Injectables to Optimize Outcomes in the Treatment of Serious Mental Illness

All sessions will be held in Eastern Time (ET).

As Dr. Stephen M. Stahl says, “Medications don’t work if you don’t take them.” Whether by conscious decision or otherwise, many patients with a serious mental illness (SMI), such as schizophrenia or bipolar disorder, do not adhere to daily oral treatment. The lack of consistent treatment can have myriad dire consequences. In this half-day program, we will explore the how, why, when, and for whom of utilizing long-acting injectable (LAI) formulations to treat SMI, including early in the disease course. Practical tips for forming a strong therapeutic alliance with patients living with an SMI and for selecting, initiating, and maintaining treatment with an LAI formulation best suited to the individual needs and wishes of the patient with SMI will be provided.